Treatment of Keloids Using Plasma Skin Regeneration Combined with Radiation Therapy Under the Evaluation of Patient and Observer Scar Assessment Scale

© 2021 Ting et al..

PURPOSE: Keloids are caused by uncontrolled excessive proliferation of fibrous tissue. Multiple treatment strategies including steroid injection, surgical excision, laser therapy and radiation therapy have been reported. Few studies have evaluated the performance of plasma skin regeneration (PSR) in the treatment of keloid. This study aimed to evaluate the effectiveness of PSR combined with radiation therapy for keloids on different body parts.

PATIENTS AND METHODS: A total of 71 patients with 98 keloids were enrolled in this study. Keloids <4 mm thick underwent single-dose PSR, while keloids ≥4 mm thick were administered compound betamethasone injection beforehand. Radiation therapy was administered after 24 hours and again 7 days later after PSR. The outcome was evaluated using the patient and observer scar assessment scale at 12 months post-treatment.

RESULTS: Patient-reported average scores for all keloids significantly decreased from 35.05±9.94 to 21.84±7.04 (p < 0.05). Keloids on face and neck, chest, and back responded better than those on shoulders and limbs. The recurrence rate was observed to be 15.3% (15 out of 98). Adverse effects were mild.

CONCLUSION: PSR combined with radiation therapy is an effective and safe strategy to treat keloids. Location could be a factor that affects curative effects.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:14

Enthalten in:

Clinical, cosmetic and investigational dermatology - 14(2021) vom: 11., Seite 981-989

Sprache:

Englisch

Beteiligte Personen:

Ting, Wenyun [VerfasserIn]
Chong, Yuming [VerfasserIn]
Xu, Jing [VerfasserIn]
Huang, Jiuzuo [VerfasserIn]
Yu, Nanze [VerfasserIn]
Liu, Zhifei [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
Keloid
POSAS
Plasma skin regeneration
Radiation therapy
Recurrence rate

Anmerkungen:

Date Revised 25.04.2022

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.2147/CCID.S321348

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM329296167